Category Archive: Speakers

Dec 04

Steven B. Engle

CEO, Averigon Consulting Steve EngleSteve Engle has more than 20 years of leadership experience in the biotechnology, drug delivery and device industries. He is CEO of Averigon Consulting, an advisory firm to the life science industry. Mr. Engle was Chairman and CEO of XOMA, a developer of monoclonal antibody therapeutics including XOMA 052, an anti-inflammatory …

Continue reading »

Oct 16

Steven T. Walker, M.S., P.G.

Co-Founder Abigail Alliance For Better Access To Developmental Drugs Steven T. Walker, M.S., P.G.Mr. Walker is Co-Founder of the Abigail Alliance for Better Access to Developmental Drugs. His responsibilities include regulatory and legislative efforts, scientific direction, advocacy for patient’s rights, spokesperson for the alliance on regulatory and scientific issues, and author of papers, articles and …

Continue reading »

Sep 27

Nicole Boice

President & Founder, RARE Project Nicole BoiceNicole founded RARE Project in 2008, with the goal of helping families affected by rare disease connect with tools and resources and find support more quickly. She was personally touched by rare disease through a friend and their son that struggled to find a diagnosis for 2.5 years. Once …

Continue reading »

Jun 28

Carin Canale-Theakston

Carin Canale-Theakston is the president and founder of Canale Communications Inc. In her role as president, Carin works closely with client teams, having provided senior level strategy to more than 125 life science companies of all shapes and sizes ranging from pre-series A financing to billion dollar public companies such as Amgen and Johnson & …

Continue reading »

Jun 27

Gautam Kollu

Vice President (Commercial Operations), Exelixis Gautam KolluGautam Kollu is VP of Commercial at Exelixis, where his team is charged with distribution, marketing and customer management efforts for cabozantinib, a novel oncology therapeutic. Most recently, he oversaw the strategic marketing initiatives for Exelixis’s portfolio of oncology compounds. Previously, Gautam worked at Genentech, where he led a …

Continue reading »

Jun 12

J. Craig Venter, Ph.D.

J. Craig Venter, Ph.D.J. Craig Venter, Ph.D., is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. He is Founder, Chairman, and CEO of the J. Craig Venter Institute (JCVI), a not-for-profit, research organization with approximately 300 scientists and staff dedicated to human, microbial, plant, …

Continue reading »

Jun 10

Francois Meurgey

President, Oukelos Consulting Francois Meurgey is President of Oukelos, a consultancy based in Brussels, and was formerly Vice President of Marketing at UCB in Brussels. His prior appointments include marketing and strategy positions at Merck and Pharmacia (now Pfizer). He holds an MBA from New York University.

Apr 14

Patrick Soon-Shiong, M.D.

Patrick Soon-Shiong, M.D.One of the preeminent scientific and medical minds in the world today, Dr. Patrick Soon-Shiong has lent vision, voice, and action to the power of convergence – applying the limitless potential of collaborative science and technology on a personal level – at the speed of thought. A physician, surgeon and scientist, he has …

Continue reading »

Apr 10

Camille Samuels

Managing Director, Versant Ventures Camille SamuelsCamille Samuels specializes in early-stage biotechnology and consumer medicine investing. Cami brings 17 years of venture capital and operating experience to her portfolio companies. She enjoys helping talented entrepreneurs build exceptional companies. Cami joined Versant in early 2000, shortly after its formation. Prior to Versant, she was responsible for business …

Continue reading »